Hot Medical Stocks To Buy Right Now

tags:ONCE,OSUR,KTF,EXPD,GRIF,

First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its analyst recommendations, earnings, institutional ownership, profitability, risk, valuation and dividends.

Analyst Recommendations

Get First Choice Healthcare Solutions alerts:

This is a breakdown of current recommendations and price targets for First Choice Healthcare Solutions and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score First Choice Healthcare Solutions 0 1 2 0 2.67 First Choice Healthcare Solutions Competitors 121 521 612 31 2.43

First Choice Healthcare Solutions presently has a consensus price target of $2.50, indicating a potential upside of 110.08%. As a group, “Medical laboratories” companies have a potential downside of 6.33%. Given First Choice Healthcare Solutions’ stronger consensus rating and higher probable upside, equities research analysts clearly believe First Choice Healthcare Solutions is more favorable than its peers.

Hot Medical Stocks To Buy Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors' Opinion:

• [By Shane Hupp]

  Guggenheim began coverage on shares of Spark Therapeutics (NASDAQ:ONCE) in a research note issued to investors on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $70.00 price objective on the biotechnology company’s stock.

• [By Chris Lange]

  Spark Therapeutics Inc. (NASDAQ: ONCE) shares more than doubled in Tuesday's session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions in the future, at least according to one analyst.

• [By Cory Renauer]

  All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others. 

  Company (Symbol) One-Month Loss  Market Capitalization Idera Pharmaceuticals (NASDAQ:IDRA) (35%) $199.7 million Spark Therapeutics (NASDAQ:ONCE) (38%) $2.16 billion Tesaro (NASDAQ:TSRO) (40%) $1.49 billion

  Here's what needs to happen if these stocks are going to mount a comeback.

• [By Motley Fool Transcribing]

  Spark Therapeutics (NASDAQ:ONCE) Q4 2018 Earnings Conference CallFeb. 19, 2019 8:30 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator 

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Buy Right Now: OraSure Technologies, Inc.(OSUR)

Advisors' Opinion:

• [By Joseph Griffin]

  OraSure Technologies (NASDAQ:OSUR) has earned a consensus recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $20.00.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on OraSure Technologies (OSUR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  SurModics (NASDAQ: OSUR) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations.

• [By Lisa Levin]

   

  Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N
• [By Joseph Griffin]

  Wells Fargo & Company MN lowered its position in OraSure Technologies, Inc. (NASDAQ:OSUR) by 6.8% during the second quarter, Holdings Channel reports. The institutional investor owned 538,402 shares of the medical instruments supplier’s stock after selling 39,050 shares during the period. Wells Fargo & Company MN’s holdings in OraSure Technologies were worth $8,867,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Motley Fool Transcribers]

  OraSure Technologies Inc  (NASDAQ:OSUR)Q4 2018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Hot Medical Stocks To Buy Right Now: Scudder Municiple Income Trust(KTF)

Advisors' Opinion:

• [By Stephan Byrd]

  Fiera Capital Corp raised its holdings in shares of Deutsche Municipal Income Trust (NYSE:KTF) by 46.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 353,686 shares of the investment management company’s stock after purchasing an additional 111,410 shares during the quarter. Fiera Capital Corp’s holdings in Deutsche Municipal Income Trust were worth $3,898,000 at the end of the most recent quarter.

• [By Shane Hupp]

  TRADEMARK VIOLATION NOTICE: “DWS Municipal Income Trust (KTF) Plans $0.04 Monthly Dividend” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/4150549/dws-municipal-income-trust-ktf-plans-0-04-monthly-dividend.html.

Hot Medical Stocks To Buy Right Now: Expeditors International of Washington, Inc.(EXPD)

Advisors' Opinion:

• [By Max Byerly]

  Pensionfund Sabic reduced its stake in shares of Expeditors International of Washington (NASDAQ:EXPD) by 30.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,800 shares of the transportation company’s stock after selling 10,000 shares during the quarter. Pensionfund Sabic’s holdings in Expeditors International of Washington were worth $1,676,000 as of its most recent SEC filing.

• [By Ethan Ryder]

  Baird Financial Group Inc. increased its position in shares of Expeditors International of Washington (NASDAQ:EXPD) by 10.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 18,771 shares of the transportation company’s stock after purchasing an additional 1,760 shares during the quarter. Baird Financial Group Inc.’s holdings in Expeditors International of Washington were worth $1,372,000 at the end of the most recent quarter.

• [By Stephan Byrd]

  News articles about Expeditors International of Washington (NASDAQ:EXPD) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Expeditors International of Washington earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the transportation company an impact score of 46.7570916317495 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Dan Caplinger]

  Tuesday saw an up-and-down session on Wall Street, with major benchmarks trading on either side of the unchanged mark before finishing the day flat. Many investors kept most of their attention on Washington, where the White House announced that the U.S. would withdraw from the deal that the previous administration made with Iran concerning nuclear development. The withdrawal was largely expected, and although crude oil and other commodities were volatile leading up to the final decision, most other financial markets seemed prepared for the announcement. Even on a lackluster day, some companies had good news that lifted their shares substantially. Expeditors International of Washington (NASDAQ:EXPD), Valeant Pharmaceuticals International (NYSE:VRX), and SeaWorld Entertainment (NYSE:SEAS) were among the best performers on the day. Here's why they did so well.

Hot Medical Stocks To Buy Right Now: Griffin Industrial Realty, Inc.(GRIF)

Advisors' Opinion:

• [By Shane Hupp]

  Wells Fargo & Company MN increased its position in Griffin Land & Nurseries, Inc. (NASDAQ:GRIF) by 155.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,876 shares of the financial services provider’s stock after purchasing an additional 2,358 shares during the quarter. Wells Fargo & Company MN owned approximately 0.08% of Griffin Land & Nurseries worth $142,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  Gazit Globe (NASDAQ: GRIF) and Griffin Industrial Realty (NASDAQ:GRIF) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

• [By Stephan Byrd]

  Griffin Industrial Realty (NASDAQ:GRIF) and NEW WORLD Dev L/ADR (OTCMKTS:NDVLY) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.